Organization | Lindenwood University

Lindenwood University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2018

NCT04411173

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Laboratory Director | Lindenwood University

Active Ingredients

Drugs in Other Trials (11)

bacillus coagulans (2 trials)

berberine (1 trial)

beta-aminoisobutyric acid (1 trial)

caffeine (1 trial)

cow milk (1 trial)

creatine (2 trials)

dihydroberberine (1 trial)

dileucine (1 trial)

leucine (1 trial)

maltodextrin (1 trial)

whey protein (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 9
# of Trial APIs: 11